Clinical Trial Update: Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on pelvic exenteration for recurrent cervical cancer, with completed status across cervical cancer subtypes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenocarcinoma
• Cervical Adenosquamous Carcinoma
• Cervical Cancer
• Cervical Small Cell Carcinoma
• Cervical Squamous Cell Carcinoma

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 2 | Status: COMPLETED